Why GE HealthCare Technologies Inc’s (GEHC) Stock Is Down 14.28%

By Cynthia McLaughlin
April 30, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate GE HealthCare Technologies Inc before investing.

In this article, we go over a few key elements for understanding GE HealthCare Technologies Inc’s stock price such as:

  • GE HealthCare Technologies Inc’s current stock price and volume
  • Why GE HealthCare Technologies Inc’s stock price changed recently
  • Upgrades and downgrades for GEHC from analysts
  • GEHC’s stock price momentum as measured by its relative strength

About GE HealthCare Technologies Inc (GEHC)

Before we jump into GE HealthCare Technologies Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Want to learn more about GE HealthCare Technologies Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about GE HealthCare Technologies Inc.

Learn More About A+ Investor

GE HealthCare Technologies Inc’s Stock Price as of Market Close

As of April 30, 2024, 4:00 PM, CST, GE HealthCare Technologies Inc’s stock price was $76.24.

GE HealthCare Technologies Inc is down 14.28% from its previous closing price of $88.94.

During the last market session, GE HealthCare Technologies Inc’s stock traded between $86.30 and $89.18. Currently, there are 455.00 million shares of GE HealthCare Technologies Inc stock available for purchase.

GE HealthCare Technologies Inc’s price-earnings (P/E) ratio is currently at 29.3, which is low compared to the Advanced Medical Equipment & Technology industry median of 36.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

GE HealthCare Technologies Inc Stock Price History

GE HealthCare Technologies Inc’s (GEHC) price is currently down 16.14% so far this month.

During the month of April, GE HealthCare Technologies Inc’s stock price has reached a high of $91.46 and a low of $76.08.

Over the last year, GE HealthCare Technologies Inc has hit prices as high as $94.50 and as low as $62.35. Year to date, GE HealthCare Technologies Inc’s stock is up 30.59%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused GE HealthCare Technologies Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 29, 2024, there were 0 analysts who downgraded GE HealthCare Technologies Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate GE HealthCare Technologies Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on GE HealthCare Technologies Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

GE HealthCare Technologies Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about GE HealthCare Technologies Inc (GEHC) by visiting AAII Stock Evaluator.

Relative Price Strength of GE HealthCare Technologies Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 29, 2024, GE HealthCare Technologies Inc has a weighted four-quarter relative price strength of 1.34%, which translates to a Momentum Score of 70 and is considered to be Strong.

Want to learn more about how GE HealthCare Technologies Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

GE HealthCare Technologies Inc Stock Price: Bottom Line

As of April 30, 2024, GE HealthCare Technologies Inc’s stock price is $76.24, which is down 14.28% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like GE HealthCare Technologies Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.